Tianjin Medical University General Hospital
Clinical trials sponsored by Tianjin Medical University General Hospital, explained in plain language.
-
Drug trial aims to halt devastating nerve attacks
Disease control TerminatedThis study aimed to see if the drug eculizumab could quickly reduce disability during sudden, severe attacks of neuromyelitis optica spectrum disorder (NMOSD). It planned to test this in adults who tested positive for a specific antibody and were having a new attack affecting the…
Phase: PHASE2 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Apr 02, 2026 05:57 UTC
-
New hope for rare brain disease: trial tests repurposed drug to stop relapses
Disease control OngoingThis study is testing if the drug tocilizumab is safe and effective for controlling Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), a rare autoimmune condition that attacks the brain and nerves. It will involve about 102 participants aged 12 and older who…
Phase: PHASE2, PHASE3 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC